LLMpediaThe first transparent, open encyclopedia generated by LLMs

Laurent Lellouch

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 42 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted42
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Laurent Lellouch
NameLaurent Lellouch
Birth date1940
Birth placeNice, France
NationalityFrench
FieldsEpidemiology, Biostatistics, Public Health
WorkplacesHôpital Broussais, Université Paris Descartes, INSERM
Alma materUniversité de Paris, École des Hautes Études en Sciences Sociales
Known forClinical trial methodology, randomized controlled trials, observational study methods, meta-analysis

Laurent Lellouch Laurent Lellouch was a French physician, epidemiologist, and biostatistician noted for methodological innovations in clinical trials and observational research. He worked at major French institutions and collaborated internationally across academic centers, regulatory agencies, and public health organizations. His work influenced randomized controlled trial design, outcome measurement, and meta-analytic synthesis used by investigators, guideline panels, and health technology assessors.

Early life and education

Lellouch was born in Nice and completed medical training at the Université de Paris before pursuing specialized training in epidemiology and statistics at institutions including the École des Hautes Études en Sciences Sociales and research units affiliated with INSERM. During formative years he was exposed to clinicians from Hôpital Broussais and epidemiologists with ties to Karolinska Institute, London School of Hygiene & Tropical Medicine, and Johns Hopkins Bloomberg School of Public Health, fostering early links between French clinical practice and Anglo-American methodological traditions. He engaged with contemporaries influenced by figures associated with Randomized controlled trial development, the Cochrane Collaboration, and post‑war clinical research networks in Europe.

Scientific career

Lellouch held appointments at Hôpital Broussais and Université Paris Descartes and collaborated widely with researchers from institutions such as INSERM, Institut Pasteur, Harvard Medical School, University of Oxford, and McMaster University. He served on advisory panels for regulatory and guideline bodies including European Medicines Agency, national health agencies in France, and international consortia linked to the World Health Organization and the International Committee of Medical Journal Editors. His career spanned the maturation of evidence synthesis movements exemplified by the Cochrane Collaboration and the rise of trial registries influenced by the International Committee of Medical Journal Editors policies and deliberations at the U.S. Food and Drug Administration.

Major contributions and research

Lellouch made foundational contributions to the methodology of randomized trials and observational studies. He worked on issues of randomization, allocation concealment, and pragmatic trial designs reflecting debates associated with the British Medical Journal and New England Journal of Medicine editorial movements. He advanced methods for composite and patient‑centered outcomes, building on concepts discussed at meetings involving the International Society for Clinical Biostatistics and researchers from University College London and Yale School of Medicine. His publications addressed confounding and adjustment techniques that relate to approaches developed at University of Washington, Karolinska Institute, and McMaster University.

Lellouch participated in methodological dialogues about meta‑analysis alongside investigators tied to the Cochrane Collaboration, Campbell Collaboration, and statisticians who contributed to the development of trial synthesis standards later reflected in guidance from CONSORT and PRISMA initiatives. He evaluated biases in observational databases and registries associated with hospitals such as Hôpital Cochin and health agencies like Agence nationale de sécurité du médicament et des produits de santé in France, interacting with analysts from Centers for Disease Control and Prevention and European public health institutes.

Awards and honors

Over his career Lellouch received recognition from French and international societies. He was honored by academic units at Université Paris Descartes and received awards from professional organizations connected to the International Epidemiological Association and the European Society for Clinical Investigation. His methodological impact was acknowledged in symposia sponsored by institutions including INSERM, Institut Pasteur, and European Medicines Agency, and through honorary lectures at centers such as Harvard School of Public Health and London School of Hygiene & Tropical Medicine.

Selected publications

- Lellouch L., co‑authors. Papers on randomized trial methodology and outcome measurement published in venues such as the New England Journal of Medicine, Lancet, and BMJ addressing trial design, composite endpoints, and pragmatic trials. - Methodological articles on observational study biases and adjustment techniques appearing in journals linked to the International Journal of Epidemiology, American Journal of Epidemiology, and specialty journals associated with European Society for Clinical Investigation readership. - Contributions to collaborative reports and guidance documents for organizations including the World Health Organization and regulatory discussions echoing principles advanced by the Cochrane Collaboration and CONSORT group. (Selected titles reflect broad influence across clinical research literature and international guideline development.)

Personal life and legacy

Lellouch maintained professional ties across Europe and North America, mentoring researchers who later joined institutions such as Harvard Medical School, University of Oxford, McMaster University, and Karolinska Institute. His legacy persists in trialists’ attention to design rigor advocated by groups like CONSORT and in the analytical approaches adopted by systematic reviewers associated with the Cochrane Collaboration and PRISMA network. His work is cited in contemporary debates at agencies such as the European Medicines Agency and the U.S. Food and Drug Administration and continues to inform training programs at Université de Paris and public health schools worldwide.

Category:French epidemiologists Category:Biostatisticians Category:1940 births